Risk factors and outcome of COVID-19 in patients with hematological malignanciesJosé Luís Piñana, Anna Sureda, Alejandro Luna et al.|Experimental Hematology and Oncology|2020Cited by 159
Comparable survival between HIV+ and HIV− non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantationJosé L. Díez‐Martín, Anna Sureda, Pascual Balsalobre et al.|Blood|2009Cited by 143
Prolonged survival of patients with angioimmunoblastic T‐cell lymphoma after high‐dose chemotherapy and autologous stem cell transplantation. The GELTAMO experienceJosé Rodríguez, Eulogio Conde, Antonio Gutiérrez et al.|European Journal Of Haematology|2007Cited by 60
Effect of chemotherapy with alkylating agents on the yield of CD34+ cells in patients with multiple myeloma. Results of the Spanish Myeloma Group (GEM) Study.Javier de la Rubia, Jesús F. San Miguel, Joan Bladé et al.|PubMed|2006Cited by 55
Autologous stem cell transplantation for primary refractory Hodgkin’s disease: results and clinical variables affecting outcomeM. Constans, E. Condé, Anna Sureda et al.|Annals of Oncology|2003Cited by 46